[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351481-105":59,"doc-detail-351481-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multi-omics-analysis-of-tyms-as-a-prognostic-biomarker-and-therapeutic-target-for-lung-adenocarcinoma","Multi-Omics Analysis of TYMS as a Prognostic Biomarker and Therapeutic Target for Lung Adenocarcinoma","","Lung adenocarcinoma (LUAD) shows poor prognosis due to challenges in early diagnosis and treatment resistance. Thymidylate synthetase (TYMS), an essential DNA synthesis enzyme, has been linked to worse outcomes in several cancers, but its multi-omics features in LUAD are insufficiently characterized. This study integrates transcriptomic, proteomic, and genomic data to define TYMS expression, prognostic performance, immune microenvironment links, and therapeutic potential in LUAD.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-omics-analysis-of-tyms-as-a-prognostic-biomarker-and-therapeutic-target-for-lung-adenocarcinoma/351481/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-omics-analysis-of-tyms-as-a-prognostic-biomarker-and-therapeutic-target-for-lung-adenocarcinoma/351481.png","ImageObject",300,407,{"name":92,"@type":93},"Angel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of this study on TYMS in LUAD?","Question",{"text":112,"@type":113},"The study integrates multi-omics data to characterize TYMS expression patterns, prognostic value, immune microenvironment interactions, and therapeutic potential in lung adenocarcinoma.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What do the analyses show about TYMS expression and prognosis?",{"text":117,"@type":113},"TYMS is significantly overexpressed at both mRNA and protein levels in LUAD tissue, and high TYMS expression correlates with earlier tumor staging, higher histological grade, and poor prognosis.",{"name":119,"@type":110,"acceptedAnswer":120},"How is TYMS linked to immune features and pathway activity?",{"text":121,"@type":113},"TYMS expression associates with immune cell infiltration, including negative correlation with B-cell activity and positive correlation with neutrophil infiltration, and it relates to immune markers such as CTLA4 and PDCD1, alongside pathway enrichment involving p53/Rb and mTOR signaling.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351481,1790377827,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Cancer Medicine  \nRESEARCH ARTICLE  OPEN ACCESS   \nMulti-Omics Analysis of TYMS as a Prognostic Biomarker and Therapeutic Target for Lung Adenocarcinoma  \nHansen Shi1,2 | Peijun Zhang1 | Jiayi Chen3 | Hua Li4 | Xiaohuai Zhang5 | Biyun zeng1 | Tiancai Liu2  | Tao Zeng1   \n1Laboratory Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, People's Republic of China | 2Key Laboratory of Antibody Engineering of Guangdong Higher Education Institutes, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, People's Republic of China | 3Medical Laboratory Center, Foresea Life Insurance Guangzhou General Hospital, Guangzhou, Guangdong, People's Republic of China | 4Department of Clinical Laboratory, The Fourth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China | 5Clinical Medical Laboratory Center, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China  \nCorrespondence: Tiancai Liu ([liutc@smu.edu.cn](liutc@smu.edu.cn)) | Tao Zeng ([zengt@smu.edu.cn](zengt@smu.edu.cn))  \nReceived: 5 November 2025 | Revised: 7 March 2026 | Accepted: 2 April 2026  \nKeywords: bioinformatics | biomarkers | LUAD | multi-omics analysis | prognostic markers | therapeutic targets | tumour immune microenvironment | TYMS  \nABSTRACT  \nLung adenocarcinoma (LUAD) is a predominant form of lung cancer with poor prognosis due to early diagnosis challenges and treatment resistance. Thymidylate synthetase (TYMS), a key enzyme in DNA synthesis, has been associated with poor prognosis in multiple cancers, yet its multi-omics characteristics in LUAD remain systematically uncharacterized. This study focuses specifically on LUAD, integrating transcriptomic, proteomic, and genomic data to elucidate TYMS expression patterns, prognostic value, immune microenvironment interactions, and therapeutic potential.  \nUsing data from The Cancer Genome Atlas (TCGA), the Clinical Proteomic Tumour Analysis Consortium (CPTAC), the GenomeTissue Expression Project (GTEx), the Gene Expression Profile Interaction Analysis (GEPIA2), etc., we conducted comprehensive bioinformatics analyses of TYMS in LUAD. TYMS showed significant overexpression at both mRNA and protein levels in LUAD tissue. High TYMS expression correlated with earlier tumour staging, higher histological grade, and poor prognosis. Functional enrichment analysis revealed TYMS involvement in p53/Rb and mammalian Target of Rapamycin (mTOR) signalling pathways. TYMS expression was associated with immune cell infiltration, showing negative correlation with B-cell activity and positive correlation with neutrophil infiltration, as well as significant association with Cytotoxic T Lymphocyte-Associated Protein 4 (CTLA4), Programmed Death-1 (PDCD1, PD-1), and Interleukin-6 (IL-6) . Somatic copy number variation (SCNA) analysis indicated that TYMS amplification was linked to poor prognosis and enriched in the folate metabolism pathways. Drug sensitivity analysis demonstrated that high TYMS expression positively correlated with sensitivity to Afatinib and Gefitinib, but negatively correlated with Methotrexate and Vorinostat.  \nIn conclusion, TYMS is upregulated in LUAD and may serve as an independent prognostic biomarker and therapeutic target.  \n1 | Introduction  \nLUAD, the most common histological subtype of non-small cell lung cancer (NSCLC), is a leading cause of cancer-related deaths worldwide [1] . Patients with LUAD have a poor prognosis,  \nprimarily attributable to difficulties in early diagnosis, limited treatment options, and the development of treatment resistance [2–4] . Despite advances in diagnosis and treatment, the lack of reliable biomarkers for early detection and prognostic prediction remains a significant challenge [5, 6] . Therefore, there is an  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCo","cbCaid0Jp1C548kw","https://ap.wps.com/l/cbCaid0Jp1C548kw","pdf",3967022,15,"English","# Abstract\n# Introduction","[{\"question\":\"What is the main focus of this study on TYMS in LUAD?\",\"answer\":\"The study integrates multi-omics data to characterize TYMS expression patterns, prognostic value, immune microenvironment interactions, and therapeutic potential in lung adenocarcinoma.\"},{\"question\":\"What do the analyses show about TYMS expression and prognosis?\",\"answer\":\"TYMS is significantly overexpressed at both mRNA and protein levels in LUAD tissue, and high TYMS expression correlates with earlier tumor staging, higher histological grade, and poor prognosis.\"},{\"question\":\"How is TYMS linked to immune features and pathway activity?\",\"answer\":\"TYMS expression associates with immune cell infiltration, including negative correlation with B-cell activity and positive correlation with neutrophil infiltration, and it relates to immune markers such as CTLA4 and PDCD1, alongside pathway enrichment involving p53/Rb and mTOR signaling.\"}]","Multi-Omics Analysis of TYMS as a Prognostic Biomarker and Therapeutic Target for Lung Adenocarcinoma | PDF",1790094360,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ebb41fff840e91260399686e22e6c7e3.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0aac6d4ba53180b8b5187529454cee13.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8b4e37a9e2fcdeccbf19380715d42e1.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/370e36b7f12dadcdb5cdb705c2da14cc.webp",980,1287]